Economist Sanjay Reddy (New School for Social Research) and I discuss the impact of the pandemic on global poverty, the role that intellectual property plays in vaccine development and distribution, and the ethical and economic case for a "People's Vaccine." How might suspending existing understandings of intellectual property in the case of vaccines for Covid-19 - while compensating pharmaceutical companies for research and development - enable a more efficient distribution of the vaccine?
